Taken together, these results demonstrate that both GluN2A- and GluN2B-containing NMDARs can provide sufficient Ca2+ for BK activation, consistent with our data from BC-L5PN basal dendrites (Fig. 1F). The gene discussed is KNG1; the disease is breast cancer.